Cited 0 times in 
Cited 0 times in 
Ticagrelor monotherapy for acute coronary syndromes - Authors' reply
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Valgimigli, Marco | - |
| dc.contributor.author | Hong, Sung-Jin | - |
| dc.contributor.author | Gragnano, Felice | - |
| dc.contributor.author | Hong, Myeong Ki | - |
| dc.date.accessioned | 2025-11-10T07:37:36Z | - |
| dc.date.available | 2025-11-10T07:37:36Z | - |
| dc.date.created | 2025-08-21 | - |
| dc.date.issued | 2025-04 | - |
| dc.identifier.issn | 0140-6736 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/208563 | - |
| dc.language | English | - |
| dc.publisher | Elsevier | - |
| dc.relation.isPartOf | LANCET | - |
| dc.relation.isPartOf | LANCET | - |
| dc.title | Ticagrelor monotherapy for acute coronary syndromes - Authors' reply | - |
| dc.type | Article | - |
| dc.contributor.googleauthor | Valgimigli, Marco | - |
| dc.contributor.googleauthor | Hong, Sung-Jin | - |
| dc.contributor.googleauthor | Gragnano, Felice | - |
| dc.contributor.googleauthor | Hong, Myeong Ki | - |
| dc.identifier.doi | 10.1016/S0140-6736(25)00365-4 | - |
| dc.relation.journalcode | J02152 | - |
| dc.identifier.eissn | 1474-547X | - |
| dc.identifier.pmid | 40287232 | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0140673625003654 | - |
| dc.subject.keyword | Acetylsalicylic Acid | - |
| dc.subject.keyword | Ticagrelor | - |
| dc.subject.keyword | Acetylsalicylic Acid | - |
| dc.subject.keyword | Ticagrelor | - |
| dc.subject.keyword | Acute Coronary Syndrome | - |
| dc.subject.keyword | Dual Antiplatelet Therapy | - |
| dc.subject.keyword | Hazard Ratio | - |
| dc.subject.keyword | Human | - |
| dc.subject.keyword | Knowledge | - |
| dc.subject.keyword | Letter | - |
| dc.subject.keyword | Major Bleeding | - |
| dc.subject.keyword | Monotherapy | - |
| dc.subject.keyword | Drug Comparison | - |
| dc.subject.keyword | Drug Therapy | - |
| dc.subject.keyword | Letter | - |
| dc.subject.keyword | Male | - |
| dc.subject.keyword | Therapy | - |
| dc.contributor.affiliatedAuthor | Hong, Sung-Jin | - |
| dc.contributor.affiliatedAuthor | Hong, Myeong Ki | - |
| dc.identifier.scopusid | 2-s2.0-105003246779 | - |
| dc.identifier.wosid | 001480714300001 | - |
| dc.citation.volume | 405 | - |
| dc.citation.number | 10488 | - |
| dc.citation.startPage | 1463 | - |
| dc.citation.endPage | 1464 | - |
| dc.identifier.bibliographicCitation | LANCET, Vol.405(10488) : 1463-1464, 2025-04 | - |
| dc.identifier.rimsid | 88728 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Acetylsalicylic Acid | - |
| dc.subject.keywordAuthor | Ticagrelor | - |
| dc.subject.keywordAuthor | Acetylsalicylic Acid | - |
| dc.subject.keywordAuthor | Ticagrelor | - |
| dc.subject.keywordAuthor | Acute Coronary Syndrome | - |
| dc.subject.keywordAuthor | Dual Antiplatelet Therapy | - |
| dc.subject.keywordAuthor | Hazard Ratio | - |
| dc.subject.keywordAuthor | Human | - |
| dc.subject.keywordAuthor | Knowledge | - |
| dc.subject.keywordAuthor | Letter | - |
| dc.subject.keywordAuthor | Major Bleeding | - |
| dc.subject.keywordAuthor | Monotherapy | - |
| dc.subject.keywordAuthor | Drug Comparison | - |
| dc.subject.keywordAuthor | Drug Therapy | - |
| dc.subject.keywordAuthor | Letter | - |
| dc.subject.keywordAuthor | Male | - |
| dc.subject.keywordAuthor | Therapy | - |
| dc.subject.keywordPlus | DUAL ANTIPLATELET THERAPY | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
| dc.relation.journalResearchArea | General & Internal Medicine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.